Accelerated Early Phase Decision-Making – Insider Insights to Speed Development
Access insider insights from combined perspectives of clinical pharmacology, global regulatory considerations, and private equity investors on accelerating early development timelines to go/no go decisions and early proof of concept, without shortcuts. Parexel’s early phase team and EQT LifeSciences share best practices for combining sequential early phase studies into a single protocol.
Related Insights
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Blog
Proof of product safety and efficacy: how to move ahead successfully in Phase 2 clinical development
Jan 22, 2025
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Playbook
Streamlining development in the EU: Strategies for smoother CTA submissions
Feb 27, 2025
Webinar
Regulatory roadmap for biotechs: Effective strategies for streamlined early phase development
May 6, 2025
Video
Overcoming asset transfer challenges during a merger and acquisition (M&A)
Oct 20, 2021
Article
Expedited Pathways Comparisons - US EU CHN
Oct 19, 2021
Playbook
Early-phase development strategies for navigating regulatory complexity in the EU
Apr 29, 2024
Blog
Overcoming risks in Phase 3 trials to accelerate time to market
Jan 22, 2025
Article
Maximize the efficiency of regulatory operations with five key competencies
Jul 23, 2021
Blog
Regulatory outsourcing: Applying change management best practices for smoother transitions
Jul 24, 2025
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Related Insights
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Blog
Proof of product safety and efficacy: how to move ahead successfully in Phase 2 clinical development
Jan 22, 2025
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Playbook
Streamlining development in the EU: Strategies for smoother CTA submissions
Feb 27, 2025
Webinar
Regulatory roadmap for biotechs: Effective strategies for streamlined early phase development
May 6, 2025
Video
Overcoming asset transfer challenges during a merger and acquisition (M&A)
Oct 20, 2021
Article
Expedited Pathways Comparisons - US EU CHN
Oct 19, 2021
Playbook
Early-phase development strategies for navigating regulatory complexity in the EU
Apr 29, 2024
Blog
Overcoming risks in Phase 3 trials to accelerate time to market
Jan 22, 2025
Article
Maximize the efficiency of regulatory operations with five key competencies
Jul 23, 2021
Blog
Regulatory outsourcing: Applying change management best practices for smoother transitions
Jul 24, 2025
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021